CN114010750A - 一种补肾生血抗衰的参草方 - Google Patents
一种补肾生血抗衰的参草方 Download PDFInfo
- Publication number
- CN114010750A CN114010750A CN202111404258.4A CN202111404258A CN114010750A CN 114010750 A CN114010750 A CN 114010750A CN 202111404258 A CN202111404258 A CN 202111404258A CN 114010750 A CN114010750 A CN 114010750A
- Authority
- CN
- China
- Prior art keywords
- ginseng
- kidney
- formula
- minutes
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 41
- 241000208340 Araliaceae Species 0.000 title claims abstract description 36
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 36
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 36
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 36
- 210000004369 blood Anatomy 0.000 title claims abstract description 30
- 239000008280 blood Substances 0.000 title claims abstract description 30
- 244000025254 Cannabis sativa Species 0.000 title claims abstract description 22
- 230000032683 aging Effects 0.000 title abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 37
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 17
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 17
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 17
- 240000000249 Morus alba Species 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 17
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 17
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 15
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 14
- 235000008397 ginger Nutrition 0.000 claims abstract description 14
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 13
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 13
- 108010010803 Gelatin Proteins 0.000 claims abstract description 13
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 13
- 240000007651 Rubus glaucus Species 0.000 claims abstract description 13
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 13
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 13
- 229920000159 gelatin Polymers 0.000 claims abstract description 13
- 239000008273 gelatin Substances 0.000 claims abstract description 13
- 235000019322 gelatine Nutrition 0.000 claims abstract description 13
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 13
- 239000000047 product Substances 0.000 claims abstract description 11
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 10
- 244000273928 Zingiber officinale Species 0.000 claims abstract 5
- 239000000203 mixture Substances 0.000 claims description 27
- 238000000605 extraction Methods 0.000 claims description 26
- 238000010438 heat treatment Methods 0.000 claims description 18
- 244000197580 Poria cocos Species 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 239000011550 stock solution Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 241000756042 Polygonatum Species 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 235000015203 fruit juice Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000010025 steaming Methods 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000007812 deficiency Effects 0.000 abstract description 15
- 210000004185 liver Anatomy 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 208000031975 Yang Deficiency Diseases 0.000 abstract description 4
- 208000031971 Yin Deficiency Diseases 0.000 abstract description 4
- 239000005556 hormone Substances 0.000 abstract description 4
- 229940088597 hormone Drugs 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 206010002482 Angiosclerosis Diseases 0.000 abstract description 3
- 230000002124 endocrine Effects 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000011194 food seasoning agent Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 10
- 241000234314 Zingiber Species 0.000 description 9
- 230000006870 function Effects 0.000 description 5
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 201000001962 aortic atherosclerosis Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 108010062085 ligninase Proteins 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000011514 vinification Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种补肾生血抗衰的参草方,涉及养生保健品技术领域,所述参草方的配方包括如下成分:阿胶16%;人参23%;蛹虫草12‑18%;枸杞4‑8%;覆盆子10‑14%;桂圆5‑9%;桑葚6‑10%;茯苓3‑7%;生姜3‑6%;老红糖3%,通过本发明的参草方在红糖、生姜起到调味抑菌的作用下制得的药酒适用人群除了女性气虚、血淤、阳虚、阴虚以外,还可用于男性的肾虚(阴虚、阳虚)、气虚,实现补气补肾,阴阳双调,平衡肾激素水平。在补肾方面:补肾益气,改善内分泌,平衡激素水平,延缓衰老;补血:疏肝理气、温肾健脾,实现血液对脏器的充分滋养;补气:在防止血管硬化的基础上,还能活血通络,改善血液循环。
Description
技术领域
本发明涉及养生保健品技术领域,具体涉及到一种补肾生血抗衰的参草方。
背景技术
在我国的饮食文化当中,酒作为一种常见的饮品而广泛被人们饮用,传统的酒主要是采用粗粮或作物酿制而成,使得酒的功效较为单一,为了改善人体健康,人们发明了养生酒。
肾脏是人体的重要排泄器官,调节体内的电解质和酸碱平衡;肾虚指肾脏精气阴阳不足,肾虚的症状通常表现为:男性性功能下降,女性月经不调等。
常用的补肾方式为服用补肾药酒,将补肾中药溶解于酒中,酒有“通血脉,温肠胃”等作用,酒和药配制可以增强药力及各中药成分的稳定性,药助酒力,酒助药势,从而可以提高治疗功效。目前常用浸提法制备补肾药酒,浸提法即用适当的容积和方法使药材中所含的有效成分浸出的操作。
然而,现有的药酒的原料中中药材的种类较少,且中药材的药效差异大,进而使得药酒的疗效不显著,而且,传统的药酒浸提法通常为将药材简单直接浸泡于白酒中,浸泡时间长达半年,且药材中所含的有效成分如生物碱、苷、氨基酸等不能充分释放出来,传统的浸提法提取时间长且提取率低,因此,存在待改进之处。
发明内容
针对现有技术所存在的不足,本发明目的在于提出一种补肾生血抗衰的参草方,具体方案如下:
一种补肾生血抗衰的参草方,所述参草方的配方包括如下成分:
阿胶16%;
人参23%;
蛹虫草12-18%;
枸杞4-8%;
覆盆子10-14%;
桂圆5-9%;
桑葚6-10%;
茯苓3-7%;
生姜3-6%;
老红糖3%。
进一步的,所述参草方的配方中各成分的含量优选为:
阿胶16%;
人参23%;
蛹虫草15%;
枸杞7%;
覆盆子12%;
桂圆7%;
桑葚8%;
茯苓5%;
生姜4%;
老红糖3%。
进一步的,所述参草方的生产工艺为:
步骤一,将阿胶、人参、蛹虫草、枸杞、覆盆子、桂圆、桑葚以及茯苓原料均添加在破碎机中进行粉碎,粉碎机的目数设置为10目,得到中药混合物;
步骤二,将中药混合物和纯净水按照1:1的比例进行混匀,以隔水的方式加热蒸至120分钟,之后冷却至室温;
步骤三,往冷却后的中药混合物中添加果真和酵母,在室内温度20-35度的条件下,以密封的方式发酵24-48小时;
步骤四,将发酵完成的中药混合物放入陶缸中,再往陶缸中加入黄精酒,且中药混合物与黄精酒以比例1:10进行混合,浸泡30天,得到药酒原液;
步骤五,将药酒原液放入超声仪中萃取,萃取完成后取出上清液后,过滤下方的药渣由离心机甩干,同时对上清液进行蒸馏得到蒸馏药液以及酒精,酒精冷却回收;
步骤六,往蒸馏药液中添加老红糖、生姜,加热熬制3-6小时,再冷却至室温,得到药酒制品;
步骤七,将药酒制品过滤分装入瓶,统一进行巴氏杀菌,之后进行包装。
进一步的,在所述步骤二中的加热过程依次为在100度加热10分钟,在90度加热30分钟,在80度加热20分钟,在100度加热60分钟。
进一步的,所述步骤三中的发酵的方式设置为在氧含量在8-20%、含水率在20%~35%的环境下,将灭菌后的中药混合物作为培养基接种果真和酵母。
进一步的,在所述步骤五中,萃取的方式设置为持续15-30天,每天萃取时长为50-80分钟。
进一步的,所述萃取时长为80分钟时的工作温度为25-27度,随着所述工作温度每升高2度,所述萃取时长从80分钟依次减少10分钟。
与现有技术相比,本发明的有益效果如下:
阿胶作为中药可调节人体内分泌、美容养颜、补血止血、滋阴养血、生津润肠,通过提高人体红细胞及血红蛋白的含量,进而补血以滋润皮肤;覆盆子可益肾固精缩尿、养肝明目、滋养补益,可对肝肾亏虚引起的两目发干、阳痿早泄、尿频、遗尿、遗精、滑精、眼目昏花等症状起到缓解作用,覆盆子可和枸杞协同增效实现滋补肝肾,还可和桑椹协同增效实现调理身体的肝肾功能,促进身体的健康状态,弥补精血不足的症状;
桂圆具有补血以及养血安神的作用,对于血虚引起的失眠有非常好的治疗效果,另外桂圆中富含有丰富的葡萄糖、蛋白质、维生素C和微量元素,可被人体直接吸收,可提高机体的免疫功能,此外,桂圆中含有丰富的矿物质,铁含量较高,对于缺铁性贫血有一定的治疗效果;
桑葚含有丰富的活性蛋白、维生素c、氨基酸、矿物质、花青素等,增强免疫力、促进消化,桑葚所含脂肪酸可抑制脂肪合成,分解脂肪,降低血脂,阻止脂质在血管内沉积,防止血管硬化等,而且桑葚可与枸杞协同增效用于治肾虚、须发早白、眼目昏花,另外,桑葚、茯苓协同增效起到滋阴补血、补肝益肾、生津止渴、利水渗湿、益脾和胃、安神宁心的效果;
人参不仅能大补元气、复脉固脱、补脾益肺、安神益智,还能促进人体内的代谢作用,促进骨髓细胞有丝分裂,使血中的红细胞、白细胞及骨髓中的有核细胞数量增加,从而增强骨髓的造血机能,人参也能提高心脏的收缩能力和频率,兴奋心脏,使血液流动加快,促进体内的新陈代谢,进而调整机体的营养状况和减缓体力衰退,增强抵抗力,人参皂甙能使磷脂蛋白酶活化,促进磷脂的生物合成,从而防止冠状动脉和心脏主动脉血管粥样硬化,因此,对各种心脏病比如冠心病,心绞痛,心肌营养不良等和贫血都有一定疗效;
蛹虫草作用为抗癌、防衰、减毒、护肝、补养延年,另外,蛹虫草中的虫草酸即D-甘露醇是治疗心脑血管疾病的基本药物,具有清除自由基、扩张血管、降低血压的作用。蛹虫草中的核苷酸具有抑制血小板聚集、防止心脑血栓形成,消除黄褐斑、老年斑、青春痘,抗衰防皱,养颜美容等;
枸杞的作用为调节机体免疫功能、延缓衰老、抗脂肪肝,枸杞主要功效为平补肝肾,对各种肝肾亏虚的问题都有调理作用,比如长期头晕、耳鸣、贫血、精亏、腰酸,对年轻人有滋补提神和养颜抗衰老的功效,它可以通过对肝的滋补作用来壮精益神,使人神满精足,还能预防脂肪肝,老年人吃枸杞,有降血脂、降血压的作用。枸杞含有丰富的原花青素,可以有效地增强各种脏腑功能,能改善大脑功能和对抗自由基的功能,具有明显的延缓衰老的作用;
综述,通过本发明的参草方在红糖、生姜起到调味抑菌的作用下制得的药酒适用人群除了女性气虚、血淤、阳虚、阴虚以外,还可用于男性的肾虚(阴虚、阳虚)、气虚,实现补气补肾,阴阳双调,平衡肾激素水平。在补肾方面:补肾益气,改善内分泌,平衡激素水平,延缓衰老;在补血方面:疏肝理气、温肾健脾,实现血液对脏器的充分滋养;在补气方面:在防止血管硬化的基础上,还能活血通络,改善血液循环。
具体实施方式
下面结合实施例对本发明作进一步的详细说明,但本发明的实施方式不仅限于此。
一种补肾生血抗衰的参草方,参草方的配方包括如下成分:
阿胶16%;
人参23%;
蛹虫草12-18%;
枸杞4-8%;
覆盆子10-14%;
桂圆5-9%;
桑葚6-10%;
茯苓3-7%;
生姜3-6%;
老红糖3%。
对应的,本发明还提出一种补肾生血抗衰的参草方的制酒工艺,具体工艺如下:步骤一,将阿胶、人参、蛹虫草、枸杞、覆盆子、桂圆、桑葚以及茯苓原料均添加在破碎机中进行粉碎,粉碎机的目数设置为10目,得到中药混合物;
步骤二,将中药混合物和纯净水按照1:1的比例进行混匀,以隔水的方式加热蒸至120分钟,之后冷却至室温;
步骤三,往冷却后的中药混合物中添加果真和酵母,在室内温度20-35度的条件下,以密封的方式发酵24-48小时;
步骤四,将发酵完成的中药混合物放入陶缸中,再往陶缸中加入黄精酒,且中药混合物与黄精酒以比例1:10进行混合,浸泡30天,得到药酒原液;
步骤五,将药酒原液放入超声仪中萃取,萃取完成后取出上清液后,过滤下方的药渣由离心机甩干,同时对上清液进行蒸馏得到蒸馏药液以及酒精,酒精冷却回收;
步骤六,往蒸馏药液中添加老红糖、生姜,加热熬制3-6小时,再冷却至室温,得到药酒制品;
步骤七,将药酒制品过滤分装入瓶,统一进行巴氏杀菌,之后进行包装。
优化的,在步骤二中的加热过程依次为在100度加热10分钟,在90度加热30分钟,在80度加热20分钟,在100度加热60分钟。由于中药混合物中不同中药的溶出速度不同,如此设置,在低温下加热较长时间,在高温下加热较短时间,保证每种中药能充分溶出,充分发挥中药的功效。
优化的,步骤三中的发酵的方式设置为在氧含量在8-20%、含水率在20%~35%的环境下,将灭菌后的中药混合物作为培养基接种果真和酵母。果真和酵母作为发酵菌种,微生物生长代谢过程中在益生菌的作用下产生纤维素酶、木质素酶、脂酶等多种酶类。酶是具有高度催化效率的生物催化剂,它使复杂的生物化学反应在常温常压下迅速完成。微生物有着强大的分解转化能力,同时控制发酵过程中的湿度、含氧度、温度在上述范围内,从而使得中药混合物能产生丰富的次生代谢产物。
优化的,在步骤五中,萃取的方式设置为持续15-30天,每天萃取时长为50-80分钟。萃取时长为80分钟时的工作温度为25-27度,随着工作温度每升高2度,萃取时长从80分钟依次减少10分钟。由于温度升高,药酒原液分层的速度会加快,如此设置,可根据萃取时环境温度的改变,灵活改变萃取所需要的时间,减少工作量。
实施例1
阿胶16%;
人参23%;
蛹虫草13%;
枸杞6%;
覆盆子11%;
桂圆8%;
桑葚9%;
茯苓6%;
生姜5%;
老红糖3%。
实施例2
阿胶16%;
人参23%;
蛹虫草15%;
枸杞7%;
覆盆子12%;
桂圆7%;
桑葚8%;
茯苓5%;
生姜6%;
老红糖3%。
实施例3
阿胶16%;
人参23%;
蛹虫草16%;
枸杞5%;
覆盆子13%;
桂圆6%;
桑葚7%;
茯苓7%;
生姜4%;
老红糖3%。
根据前述的药酒的制备工艺,将实施例1-3制备出对应的药酒,并对实施例1-3的药酒进行志愿者试验。
试验测试
选取300例肾虚患者服用实施例1~3对应制得的补肾药酒,每个实施例制备的补肾药酒供100例患者服用。其中男性150名,女性150名,年龄30岁~60岁,平均年龄43岁。患者临床症状表现为腰膝酸软,头晕,失眠健忘,精力不足,注意力不集中,性功能降低,肤色黯淡无光。患者每天服用100ml药酒,分早、中、晚三次服用,两个月为一个疗程。判别标准为服用本发明一个疗程后,临床症状明显好转的为临床治愈,临床症状有所改善的为有效,临床症状无明显改善的为无效。
服用一个疗程以后,服用以实施例1制备的药酒的患者临床治愈64人,有效人数为32人,无效人数4人。服用以实施例2制备的药酒的患者临床治愈78人,有效人数为20人,无效人数2人。服用以实施例3制备的药酒的患者临床治愈71人,有效人数为21人,无效人数8人。
以上所述仅是本发明的优选实施方式,本发明的保护范围并不仅局限于上述实施例,凡属于本发明思路下的技术方案均属于本发明的保护范围。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理前提下的若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (7)
1.一种补肾生血抗衰的参草方,其特征在于,所述参草方的配方包括如下成分:
阿胶16%;
人参23%;
蛹虫草12-18%;
枸杞4-8%;
覆盆子10-14%;
桂圆5-9%;
桑葚6-10%;
茯苓3-7%;
生姜3-6%;
老红糖3%。
2.根据权利要求1所述的补肾生血抗衰的参草方,其特征在于,所述参草方的配方中各成分的含量优选为:
阿胶16%;
人参23%;
蛹虫草15%;
枸杞7%;
覆盆子12%;
桂圆7%;
桑葚8%;
茯苓5%;
生姜4%;
老红糖3%。
3.根据权利要求1所述的补肾生血抗衰的参草方,其特征在于,所述参草方的生产工艺为:
步骤一,将阿胶、人参、蛹虫草、枸杞、覆盆子、桂圆、桑葚以及茯苓原料均添加在破碎机中进行粉碎,粉碎机的目数设置为10目,得到中药混合物;
步骤二,将中药混合物和纯净水按照1:1的比例进行混匀,以隔水的方式加热蒸至120分钟,之后冷却至室温;
步骤三,往冷却后的中药混合物中添加果真和酵母,在室内温度20-35度的条件下,以密封的方式发酵24-48小时;
步骤四,将发酵完成的中药混合物放入陶缸中,再往陶缸中加入黄精酒,且中药混合物与黄精酒以比例1:10进行混合,浸泡30天,得到药酒原液;
步骤五,将药酒原液放入超声仪中萃取,萃取完成后取出上清液后,过滤下方的药渣由离心机甩干,同时对上清液进行蒸馏得到蒸馏药液以及酒精,酒精冷却回收;
步骤六,往蒸馏药液中添加老红糖、生姜,加热熬制3-6小时,再冷却至室温,得到药酒制品;
步骤七,将药酒制品过滤分装入瓶,统一进行巴氏杀菌,之后进行包装。
4.根据权利要求3所述的补肾生血抗衰的参草方,其特征在于,在所述步骤二中的加热过程依次为在100度加热10分钟,在90度加热30分钟,在80度加热20分钟,在100度加热60分钟。
5.根据权利要求3所述的补肾生血抗衰的参草方,其特征在于,所述步骤三中的发酵的方式设置为在氧含量在8-20%、含水率在20%~35%的环境下,将灭菌后的中药混合物作为培养基接种果真和酵母。
6.根据权利要求3所述的补肾生血抗衰的参草方,其特征在于,在所述步骤五中,萃取的方式设置为持续15-30天,每天萃取时长为50-80分钟。
7.根据权利要求3所述的补肾生血抗衰的参草方,其特征在于,所述萃取时长为80分钟时的工作温度为25-27度,随着所述工作温度每升高2度,所述萃取时长从80分钟依次减少10分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111404258.4A CN114010750A (zh) | 2021-11-24 | 2021-11-24 | 一种补肾生血抗衰的参草方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111404258.4A CN114010750A (zh) | 2021-11-24 | 2021-11-24 | 一种补肾生血抗衰的参草方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114010750A true CN114010750A (zh) | 2022-02-08 |
Family
ID=80066095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111404258.4A Pending CN114010750A (zh) | 2021-11-24 | 2021-11-24 | 一种补肾生血抗衰的参草方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114010750A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116649516A (zh) * | 2023-06-21 | 2023-08-29 | 上海中药创新成果转化中心有限公司 | 一种补肾养血、抗衰老的植物饮料 |
-
2021
- 2021-11-24 CN CN202111404258.4A patent/CN114010750A/zh active Pending
Non-Patent Citations (1)
Title |
---|
闺格格: "从黄脸婆到女神,这瓶参草方彻底拯救了我的衰老!", 《微信公众号:闺格格》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116649516A (zh) * | 2023-06-21 | 2023-08-29 | 上海中药创新成果转化中心有限公司 | 一种补肾养血、抗衰老的植物饮料 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106562162B (zh) | 一种海棠果益生菌发酵饮品及其制备方法 | |
CN104087488B (zh) | 一种树莓复合果酒及其酿造方法 | |
CN102399658A (zh) | 一种养血驻颜的保健果酒 | |
CN108142934A (zh) | 一种活血淡斑美肤猕猴桃酵素及其制备工艺 | |
CN104893950B (zh) | 冬虫夏草发酵醋饮料的制备方法 | |
CN104544400B (zh) | 一种含冬虫夏草提取物的复配保健饮料的制备方法 | |
GB2589967A (en) | Chinese yellow rice wine containing ingredients of mulberry leaves (morus alba L.) and silkworm pupae (bombyx mori) and production method thereof | |
CN103981076B (zh) | 一种山竹保健果醋及其制备方法 | |
CN104928140A (zh) | 一种复合发酵型冬枣保健酒及其生产工艺 | |
CN106962922A (zh) | 一种滋补养颜的保健组合物、饮料及其制备方法 | |
CN102058125A (zh) | 一种灵芝保健醋及其制备方法 | |
CN106635719A (zh) | 一种百香果醋及其制备方法 | |
CN111184214A (zh) | 酵素胶原蛋白杂粮果蔬即食代餐粥及其制作方法 | |
CN114010750A (zh) | 一种补肾生血抗衰的参草方 | |
CN110731503A (zh) | 一种参杞蛹虫草片及其制备方法 | |
CN111234994A (zh) | 一种保健酒的制备方法 | |
CN106136005A (zh) | 一种牛樟芝保健乳酸饮料的制备方法 | |
CN108552449A (zh) | 一种养颜美容果醋饮料及其制备方法 | |
CN100356967C (zh) | 芦苓保健醋及其制备方法 | |
CN107969586A (zh) | 一种荷花发酵饮料及制作方法 | |
CN109363028A (zh) | 一种缓解体力疲劳的西洋参饮品制备方法 | |
CN110710624A (zh) | 银耳灵芝复合悬浮饮料及其制备方法 | |
CN104531417A (zh) | 一种安神助眠葡萄酒及其制备方法 | |
CN109112031A (zh) | 一种蜂蜜养生酒及其制备方法 | |
CN117598481A (zh) | 一种植物基抗氧化饮品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220208 |
|
RJ01 | Rejection of invention patent application after publication |